Safety and Efficacy Study of Daclatasvir (BMS-790052) Plus Pegylated Interferon-Alfa 2a and Ribavirin in Patients Coinfected With Untreated Hepatitis C Virus and HIV Virus

Clinical trial NCT01471574 · COMPLETED

Trial details

NCT number: NCT01471574
Sponsor: Bristol-Myers Squibb
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Hepatitis C, Genotype 1

Start date: 2011-12-01
Primary completion: 2014-06-01
Enrollment: 549

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.